 |
liposomal oxaliplatin |
|---|---|
| Trade Name | |
| Orphan Indication | Bile duct cancer |
| USA Market Approval | USA |
| USA Designation Date | 2017-03-30 00:00:00 |
| Sponsor | KC Specialty Therapeutics, LLC;2002 West 39th Avenue;Kansas City, Arkansas, 66103 |
| |
liposomal oxaliplatin |
|---|---|
| Trade Name | |
| Orphan Indication | Bile duct cancer |
| USA Market Approval | USA |
| USA Designation Date | 2017-03-30 00:00:00 |
| Sponsor | KC Specialty Therapeutics, LLC;2002 West 39th Avenue;Kansas City, Arkansas, 66103 |